![](https://webarchive.library.unt.edu/eot2008/20090115003416im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090115003416im_/http://www.cancer.gov/images/spacer.gif)
cisplatin![Patient Information Patient Information](https://webarchive.library.unt.edu/eot2008/20090115003416im_/http://www.cancer.gov/images/btn-patient-info.gif) An inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity. Cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA, inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links. These cross-links result in apoptosis and cell growth inhibition. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
![](https://webarchive.library.unt.edu/eot2008/20090115003416im_/http://www.cancer.gov/images/spacer.gif)
Synonyms: | ![](https://webarchive.library.unt.edu/eot2008/20090115003416im_/http://www.cancer.gov/images/spacer.gif) | CACP cis-DDP cis-diamminedichloro platinum (II) cis-diamminedichloroplatinum Cis-dichloroammine Platinum (II) Cismaplat Cisplatina cis-platinous diamine dichloride cis-platinum cis-platinum II cis-platinum II diamine dichloride CPDD Cysplatyna DDP PDD Peyrone's Chloride Peyrone's Salt Platinoxan platinum diamminodichloride | | ![](https://webarchive.library.unt.edu/eot2008/20090115003416im_/http://www.cancer.gov/images/spacer.gif) | US brand names: | ![](https://webarchive.library.unt.edu/eot2008/20090115003416im_/http://www.cancer.gov/images/spacer.gif) | Platinol Platinol-AQ | | ![](https://webarchive.library.unt.edu/eot2008/20090115003416im_/http://www.cancer.gov/images/spacer.gif) | Foreign brand names: | ![](https://webarchive.library.unt.edu/eot2008/20090115003416im_/http://www.cancer.gov/images/spacer.gif) | Abiplatin Blastolem Briplatin Cisplatyl Citoplatino Citosin Lederplatin Metaplatin Neoplatin Placis Platamine Platiblastin Platiblastin-S Platinex Platinol- AQ Platinol-AQ VHA Plus Platiran Platistin Platosin | | ![](https://webarchive.library.unt.edu/eot2008/20090115003416im_/http://www.cancer.gov/images/spacer.gif) | Abbreviation: | ![](https://webarchive.library.unt.edu/eot2008/20090115003416im_/http://www.cancer.gov/images/spacer.gif) | CDDP | | ![](https://webarchive.library.unt.edu/eot2008/20090115003416im_/http://www.cancer.gov/images/spacer.gif) | Chemical structure names: | ![](https://webarchive.library.unt.edu/eot2008/20090115003416im_/http://www.cancer.gov/images/spacer.gif) | - (SP-4-2)-diamminedichloroplatinum
- platinum, diaminedichloro-, cis- (8CI)
| | ![](https://webarchive.library.unt.edu/eot2008/20090115003416im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090115003416im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090115003416im_/http://www.cancer.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090115003416im_/http://www.cancer.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20090115003416im_/http://www.cancer.gov/images/spacer.gif) |